Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Think inside the ’box’ to increase understanding of pharmaceutical ads

28.04.2004


Direct to consumer ads can be misleading, say researchers



Pharmaceutical ads marketed directly to the consumer may minimize the risks and exaggerate the benefits of medications, often confusing the public about what drugs are most effective, but Dartmouth Medical School (DMS) researchers have found a remedy. The solution, they say, lies in a "prescription drug benefits box," a standardized table on every direct-to-consumer (DTC) ad that would present FDA approval data in clear, easy to understand terms.

Their study, appearing online in Health Affairs (http://www.healthaffairs.org), measured the public’s reaction to a benefit box that was inserted on three randomly selected DTC ads. The benefit box was modeled after the Food and Drug Administration’s (FDA) "Nutrition Facts Box" that appears on food packaging, such as cereal boxes. The box contained information obtained from the clinical trials of each drug that compared the various outcomes of patients who took the drug and those who took a placebo.


More than 200 people were interviewed after they viewed the new ads in an effort to gauge their level of understanding and whether they thought the ads would be helpful. The researchers found strong support for the benefit box, citing that "more than 90 percent [of respondents] preferred an ad which included the box to the standard version without it."

"Requiring drug benefit data in DTC ads is an important step in educating the public about prescription drugs and promoting informed decision making," said lead authors Drs. Lisa Schwartz and Steven Woloshin, associate professors of medicine and of community and family medicine at DMS.

One concern raised is that participants in the study "were very optimistic about the effectiveness of each study drug" and in each case, these perceptions dropped substantially after seeing the actual data from clinical trials in the benefit box. The study found that when shown a standard ad for one drug, 51 percent of consumers rated the drug as extremely or very effective. When the ad contained a drug benefit box, the rate dropped to just 26 percent.

While the Food and Drug Administration currently requires DTC ads to list information about potential harms, it does not require information regarding drug benefits. "The FDA recently released recommendations to pharmaceutical manufacturers on how to improve the information contained in DTC ads, yet they did not include any provisions for including drug benefit data," said co-author Dr. Gilbert Welch, professor of medicine and of community and family medicine at DMS. "To help consumers make the best decisions they can regarding medications, the FDA needs to mandate that drug benefit data be included in pharmaceutical ads."

The authors, all of whom belong to the Veteran Affairs Outcomes Group in White River Junction, Vermont, point out that DTC drug advertising has been controversial since its inception with proponents and opponents debating the educational value of the ads and their impact on the physician patient relationship. Recently, the Ministry of Health in New Zealand – the only country besides the US with legal DTC ads – reconsidered its position and is pursuing a ban on such ads.

Andy Nordhoff | EurekAlert!
Further information:
http://www.dartmouth.edu/

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

Link Discovered between Immune System, Brain Structure and Memory

26.04.2017 | Life Sciences

New survey hints at exotic origin for the Cold Spot

26.04.2017 | Physics and Astronomy

NASA examines newly formed Tropical Depression 3W in 3-D

26.04.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>